1. Home
  2. SENEA vs FTRE Comparison

SENEA vs FTRE Comparison

Compare SENEA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seneca Foods Corp.

SENEA

Seneca Foods Corp.

HOLD

Current Price

$159.45

Market Cap

949.4M

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.47

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SENEA
FTRE
Founded
1949
1996
Country
United States
United States
Employees
6895
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
949.4M
829.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
SENEA
FTRE
Price
$159.45
$9.47
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$15.39
AVG Volume (30 Days)
80.3K
1.2M
Earning Date
02-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.01
P/E Ratio
$13.21
N/A
Revenue Growth
N/A
1.00
52 Week Low
$81.00
$3.97
52 Week High
$165.26
$18.67

Technical Indicators

Market Signals
Indicator
SENEA
FTRE
Relative Strength Index (RSI) 77.72 42.51
Support Level $101.00 $8.85
Resistance Level N/A $11.22
Average True Range (ATR) 5.98 0.62
MACD 0.77 0.16
Stochastic Oscillator 83.97 53.29

Price Performance

Historical Comparison
SENEA
FTRE

About SENEA Seneca Foods Corp.

Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: